First Time Loading...

Syngene International Ltd
NSE:SYNGENE

Watchlist Manager
Syngene International Ltd Logo
Syngene International Ltd
NSE:SYNGENE
Watchlist
Price: 687.25 INR -0.28% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one SYNGENE stock under the Base Case scenario is 921.59 INR. Compared to the current market price of 687.25 INR, Syngene International Ltd is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SYNGENE Relative Value
Base Case
921.59 INR
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.7
P/S
P/S
Price to Sales
7.7
vs History
71
vs Industry
24
Median 3Y
8.9
Median 5Y
8.5
Industry
3.9
Forward
7.5
More Details
55
P/E
P/E
Price to Earnings
55
vs History
55
vs Industry
7
Median 3Y
57.4
Median 5Y
55.4
Industry
30.3
Forward
55.6
More Details
26.7
P/OCF
P/OCF
Price to OCF
26.7
vs History
71
vs Industry
22
Median 3Y
35.6
Median 5Y
33
Industry
23.2
More Details
131.4
P/FCFE
P/FCFE
Price to FCFE
131.4
vs History
44
vs Industry
5
Median 3Y
131
Median 5Y
125.7
Industry
26.9
More Details
7.1
P/B
P/B
Price to Book Value
7.1
vs History
63
vs Industry
10
Median 3Y
7.6
Median 5Y
7.3
Industry
2.5
More Details
7.4
EV/S
EV/S
Enterprise Value to Sales
7.4
vs History
73
vs Industry
24
Median 3Y
8.8
Median 5Y
8.4
Industry
3.8
Forward
7.2
More Details
10.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.4
vs History
69
vs Industry
35
Median 3Y
12.1
Median 5Y
11.7
Industry
7.7
More Details
25.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.2
vs History
69
vs Industry
16
Median 3Y
29.7
Median 5Y
28.9
Industry
16.8
Forward
25.1
More Details
40.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.5
vs History
69
vs Industry
10
Median 3Y
49.3
Median 5Y
46.5
Industry
22
Forward
39.6
More Details
25.7
EV/OCF
EV/OCF
Enterprise Value to OCF
25.7
vs History
71
vs Industry
26
Median 3Y
35.1
Median 5Y
32.3
Industry
21.1
More Details
56.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
56.1
vs History
96
vs Industry
11
Median 3Y
103.7
Median 5Y
117.7
Industry
27.6
More Details
6.5
EV/IC
EV/IC
Enterprise Value to IC
6.5
vs History
41
vs Industry
12
Median 3Y
6.6
Median 5Y
6.2
Industry
2.4
More Details

Multiples Across Competitors

SYNGENE Competitors Multiples
Syngene International Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Syngene International Ltd
NSE:SYNGENE
275B INR 7.7 55 25.2 40.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
220.8B USD 5.2 36.8 22.8 33.4
US
Danaher Corp
NYSE:DHR
180.7B USD 4.1 22.4 16.3 20.1
US
IQVIA Holdings Inc
NYSE:IQV
40.6B USD 2.7 29.9 16.3 25.3
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
CH
Lonza Group AG
SIX:LONN
37B CHF 5.5 56.5 19.4 28.5
KR
Samsung Biologics Co Ltd
KRX:207940
55.2T KRW 14.9 64.3 33.9 48.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.8B USD 9.1 47.1 32.7 39.7
IE
ICON PLC
NASDAQ:ICLR
24.8B USD 3 36.3 16.5 25.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR 7 74.5 32.1 52.7

See Also

Summary
SYNGENE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SYNGENE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SYNGENE stock valuation using valuation multiples.
Wall Street Estimates
SYNGENE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SYNGENE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.